Join to View Full Profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Kharfan Dabaja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1996 - 1999
American University of Beirut Faculty of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2005 - 2028
IN State Medical License 2001 - 2027
OK State Medical License 2002 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2016-2017
Publications & Presentations
PubMed
- Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, Soyoung Kim, Amy Moskop
Blood Neoplasia. 2026-05-01 - Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms.Zaid Abdel Rahman, Razan Mansour, Mohamed Kharfan-Dabaja, Mohammad Ma'koseh, Zaid Muhanna
Transplantation and Cellular Therapy. 2026-04-01 - Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome.Madiha Iqbal, Himil Mahadevia, Zhuo Li, Sophia Blumenfeld, Hemant Murthy
Hematology/oncology and Stem Cell Therapy. 2026-03-13
Abstracts/Posters
- A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Axicabtagene Ciloleucel in Combination with Either Rituximab or Lenalidomide in Patients...Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL):a Center f...Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Fighting Lymphoma: Treatment Options Include Alternatives to ChemotherapyJune 18th, 2024
Other Languages
- Arabic, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
